ArticleFrontiers in pharmacology2025
Bioassay-guided isolation of sesamin and fargesin from the hydroalcoholic stem extract of
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrated Phytochemical, Immunological, and Network Pharmacology Investigation of Anti-Inflammatory Lignans From Zanthoxylum armatum Fruits.Chemistry & biodiversity · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Method: Sequential fractions were prepared from the hydromethanolic stem extract of Results: Sequential ethyl acetate fraction showed the highest protein anti-denaturation and membrane stabilization activities. Afterward, sesamin and fargesin were isolated from the sequential ethyl acetate fraction. Both of them showed activity against IL12 production by conventional type 1 dendritic cells. Moreover, fargesin significantly inhibited the expression of CD80. Conclusion: The results identified bioactive compounds with potential against the pro-inflammatory dendritic cells for the first time. The findings justified the traditional use of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.